RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding RAPT Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 109 | 2 | 122 | +15 |
| Shares | 35.0M | 100.4K | 32.0M | −2.91M (−8.4%) |
| Value | $869.3M | $2.50M | $287.2M | −$579.6M (−66.9%) |
2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (39)
Institutions that held RAPT Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (24)
Institutions that held RAPT Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
Not filed for Q1 2024 yet (2)
Institutions that held RAPT Therapeutics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Trustees of Columbia University in the City of New York | 73,383 | $1.82M |
| Putnam Investments LLC | 27,027 | $671.6K |